On July 28, 2022 Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address difficult-to-treat cancers, reported that management will participate virtually in the following investor conferences during August 2022 (Press release, Sapience Therapeutics, JUL 28, 2022, View Source [SID1234617102]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2022 BTIG Biotechnology Conference, August 8-9, 2022

Sapience management will participate virtually in one-on-one meetings with investors on August 9.
2022 Wedbush PacGrow Healthcare Conference, August 9-10, 2022

Sapience management will participate virtually in a fireside chat with Robert Driscoll, Research Analyst at Wedbush, on August 10 at 8:35 am ET. Company management will also participate in virtual one-on-one meetings with investors on the same day.